Skip to content
Home/Companies/Healthcare/Alderley Analytical

Alderley Analytical

Healthcare·UK·Exited 2024·Held 9yr
Entry
2015
Hold
9yr
Exit
2024

Who owns Alderley Analytical?

Alderley Analytical was owned by River Capital through NW Fund for Biomedical (2010 vintage) from 2015 to 2024, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-06-30

River Capital
Investor
River Capital
NW Fund for Biomedical · 2010 · Healthcare

Key facts

HQUK
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2024

More from NW Fund for Biomedical

Other portfolio companies in the same fund.

Perfectus Biomed Group
Exited 2022
MedTechUK· 2013
to

More River Capital portfolio companies

From the same investor, across funds.

Deltabase
Deltabase
Active
AI/MLUK· 2026
Infinium Group
Infinium Group
Active
TMTUK· 2026
urfuture
urfuture
Active
HR TechUK· 2026
Fotenix
Active
AgTechUK· 2025
HyperFinity
Active
Data & AnalyticsUK· 2025
Mojo-CX
Active
SaaSUK· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Alderley Analytical

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alderley Analytical?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alderley Analytical.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue